Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events-Reference-Cited by-同舟云学术

Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events

Published:2013-12-02 Issue:12 Volume:8 Page:e80242
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gervasoni Cristina,Meraviglia Paola,Landonio Simona,Baldelli Sara,Fucile Serena,Castagnoli Laura,Clementi Emilio,Riva Agostino,Galli Massimo,Rizzardini Giuliano,Cattaneo Dario

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study;FA Post;J Acquir Immune Defic Syndr,2010

2. Campo R, Dejesus E, Bredeek UF, Henry K, Khanlou H, et al.. (2013) Prospective 48 Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir from Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen. Clin Infect Dis in press.

3. Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort;A Di Biagio;J Antimicrob Chemother,2013

4. Omeje I, Okwundu CI (2012) Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV. Cochrane Database Syst Rev: 5. Available: http://www.ncbi.nlm.nih.gov/pubmed/22592718. Accessed 2013 May 21.

5. Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up;C Laprise;Clin Infect Dis,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for HIV patient;BMJ Case Reports;2023-11

2. Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review;Frontiers in Endocrinology;2023-01-11

3. Antiretrovirals for People with HIV on Dialysis;AIDS Patient Care and STDs;2022-03-01

4. Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens;AIDS;2021-12-01

5. Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma;Pharmaceuticals;2021-05-13